Sign inJoin waitlistJoin the waitlist

MC

Mark Chang

Credentials:

History

Residency
2022–2025
Medical School
2018–2022

Research

Study protocol: phase II study to evaluate the effect of cetuximab monotherapy after immunotherapy with PD-1 inhibitors in patients with head and neck squamous cell cancer
Therapeutic Advances in Medical Oncology · 2024 · 4 citations
Exceptional response to cetuximab monotherapy after failure of immunotherapy with a checkpoint inhibitor in a patient with metastatic head and neck squamous cell cancer: case…
Case report · Therapeutic Advances in Medical Oncology · 2023 · 3 citations
Serendipitous synergism - an exceptional response to treatment with pembrolizumab in the course of a natural immunovirotherapy: a case report and review of the literature
Case report · Therapeutic Advances in Medical Oncology · 2022 · 3 citations

Mercedes Porosnicu
4 papers
Paul Bunch
4 papers
Chance Bloomer
3 papers · 3 as a resident
Elena Gavrila
3 papers
Kimberly Burcher
3 papers · 3 as a resident
Lara Khoury
3 papers · 3 as a resident
AS
Alexander Song
2 papers · 2 as a fellow
Christopher Sullivan
2 papers
Joshua Waltonen
2 papers
Mason Kalada
2 papers · 2 as a resident
Rebecca Kinney
2 papers
RG
Rediet Gebeyehu
2 papers